Christoffel Boshoff - 27 Jul 2023 Form 3 Insider Report for PFIZER INC (PFE)

Role
Executive Vice President
Signature
Susan E. Grant, by power of atty., for Christoffel Boshoff
Issuer symbol
PFE
Transactions as of
27 Jul 2023
Net transactions value
$0
Form type
3
Filing time
04 Aug 2023, 17:13:57 UTC
Next filing
29 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PFE Common Stock 101,554 27 Jul 2023 Direct
holding PFE Common Stock 605 27 Jul 2023 By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PFE Stock Appreciation Rights 27 Jul 2023 Common Stock 9,752 $27.34 Direct F1
holding PFE Stock Appreciation Rights 27 Jul 2023 Common Stock 8,741 $30.17 Direct F1
holding PFE Stock Appreciation Rights 27 Jul 2023 Common Stock 21,127 $31.31 Direct F1
holding PFE Stock Appreciation Rights 27 Jul 2023 Common Stock 16,688 $33.82 Direct F1
holding PFE Stock Appreciation Rights 27 Jul 2023 Common Stock 12,009 $38.71 Direct F1
holding PFE Stock Appreciation Rights 27 Jul 2023 Common Stock 17,984 $42.30 Direct F1
holding PFE Stock Appreciation Rights 27 Jul 2023 Common Stock 10,222 $45.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

Remarks:

poacb23x.htm